These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4205945)

  • 41. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):528-33. PubMed ID: 546785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of somatic antigen of Vibrio cholerae in adhesion to intestinal mucosa.
    Chitnis DS; Sharma KD; Kamat RS
    J Med Microbiol; 1982 Feb; 15(1):53-61. PubMed ID: 7143426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the action of Escherichia coli enterotoxin on the thymocyte adenylate cyclase-cyclic adenosine monophosphate system to that of cholera toxin and prostaglandin E1.
    Zenser TV; Metzger JF
    Infect Immun; 1974 Sep; 10(3):503-9. PubMed ID: 4372172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simplified method for purification of Clostridium perfringens type A enterotoxin.
    Sakaguchi G; Uemura T; Riemann HP
    Appl Microbiol; 1973 Nov; 26(5):762-7. PubMed ID: 4357653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protection afforded by anti-hemolysin against V. cholerae El Tor infection in experimental cholera.
    Chaicumpa W; Samrejrongroj P; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Jun; 11(2):294-301. PubMed ID: 7434081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification and characterization of Vibrio cholerae non-O1 heat-stable enterotoxin.
    Arita M; Takeda T; Honda T; Miwatani T
    Infect Immun; 1986 Apr; 52(1):45-9. PubMed ID: 3957432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purification and characterization of an enterotoxin from Bacteroides fragilis.
    Van Tassell RL; Lyerly DM; Wilkins TD
    Infect Immun; 1992 Apr; 60(4):1343-50. PubMed ID: 1548060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Affinity chromatography purification of Clostridium perfringens enterotoxin.
    Scott VN; Duncan CL
    Infect Immun; 1975 Sep; 12(3):536-43. PubMed ID: 170205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.
    Svennerholm AM; Holmgren J
    Infect Immun; 1976 Mar; 13(3):735-40. PubMed ID: 1270131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigenic analysis of Vibrio cholerate O1 by crossed immunoelectrophoresis.
    Kabir S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1989 Jan; 270(3):361-72. PubMed ID: 2929189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beta hemolysin: a persistent impurity in preparations of staphylococcal nuclease and enterotoxin.
    Chesbro W; Kucic V
    Appl Microbiol; 1971 Aug; 22(2):233-41. PubMed ID: 4999525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Purification and identification of pili of Vibrio cholera O139].
    Du Y; Jia W; Liu C
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Mar; 30(1):28-30. PubMed ID: 12205915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification of Vibrio cholerae soluble hemagglutinin and development of enzyme-linked immunosorbent assays for antigen and antibody quantitations.
    Svennerholm AM; Strömberg GJ; Holmgren J
    Infect Immun; 1983 Jul; 41(1):237-43. PubMed ID: 6345393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Escherichia coli enterotoxin: purification, partial characterization, and immunological observations.
    Dorner F; Jaksche H; Stöckl W
    J Infect Dis; 1976 Mar; 133 Suppl():142-56. PubMed ID: 815447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possibilities of immunization against cholera and related enterotoxic enteropathies.
    Finkelstein RA
    Dev Biol Stand; 1976; 33():102-7. PubMed ID: 955264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification and characterization of novel toxin produced by Vibrio cholerae O1.
    Walia K; Ghosh S; Singh H; Nair GB; Ghosh A; Sahni G; Vohra H; Ganguly NK
    Infect Immun; 1999 Oct; 67(10):5215-22. PubMed ID: 10496898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the antigenic determinants of cholera toxin subunits.
    Markel DE; Hejtmancik KE; Peterson JW; Martin FB; Kurosky A
    Infect Immun; 1979 Aug; 25(2):615-26. PubMed ID: 90654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Action of Vibrio cholerae enterotoxin on microorganisms].
    Andrusenko IT; Pasternak NA; Ved'mina EA; Aleksandrova IK; Shepelev AP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):52-5. PubMed ID: 6524163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.
    Fasano A; Baudry B; Pumplin DW; Wasserman SS; Tall BD; Ketley JM; Kaper JB
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5242-6. PubMed ID: 2052603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.